¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ Ãá°èÇмú´ëȸ (SoLA 2024) 2ÀÏÂ÷ : 2024-04-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ Ãá°èÇмú´ëȸ (SoLA 2024) 2ÀÏÂ÷ : 2024-04-06
±³À°ÀÏÀÚ : 2024-04-06
±³À°Àå¼Ò : ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ room1,2,3

±³À°ÁÖÁ¦ : 2024 Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ Ãá°èÇмú´ëȸ (SoLA 2024) 2ÀÏÂ÷

ÁÖÃÖ±â°ü : Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ
´ã´çÀÚ : SoLA2024 Áغñ»ç¹«±¹
¿¬¶ôó : 02-6734-1011  

À̸ÞÀÏ : sola2024@planbear.co.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 70,000¿ø  

ºñ°í ±³¼ö/ºÀÁ÷ÀÇ/°³¿øÀÇ : »çÀü µî·Ï (ȸ¿ø) 40,000¿ø,(ºñȸ¿ø)60,000¿ø. ÇöÀå µî·Ï (ȸ¿ø)50,000¿ø, (ºñȸ¿ø)70,000 ÀüÀÓÀÇ/¿µ¾ç»ç/¿îµ¿»ç/°£È£»ç/¿¬±¸¿ø/±âŸ Âü°¡ÀÚ: »çÀüµî·Ï (ȸ¿ø)20.000¿ø,(ºñȸ¿ø)40,000¿ø ÇöÀåµî·Ï(ȸ¿ø)30,000¿ø, (ºñȸ¿ø) 50,000¿ø Çлý/Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/65¼¼ ÀÌ»ó: ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 07:30~07:50 The lastes clinical trial of Atorvastatin, LODESTAR study Á¤Ã¢Èñ(¿ï»êÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 06ÀÏ Room1 07:50~08:00 Panel Discussion ()

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 08:30~08:50 Bempedoic acid ±èÇзÉ(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 08:50~09:10 Semaglutide À±Á¾Âù(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 09:10~09:30 Inclisiran ÀüÀçÇÑ(°æºÏÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 06ÀÏ Room1 09:30~10:00 Panel Discussion ()

ÈÞ½Ä 04¿ù 06ÀÏ 10:00~10:15 Break ()

±âŸ 04¿ù 06ÀÏ 10:15~10:20 Opening Address ()

±³À°½Ã°£ 04¿ù 06ÀÏ Room1,2,3 10:20~11:00 Heart-Immune-Brain network in the pathogenesis of cardio-cerebrovascular disease ¿À±¸ÅÃ(ÀÌÈ­¿©´ë »ý¸í°úÇаú)

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 12:20~12:40 Cutting edge care of pitavastatin with ezetimibe combination therapy ¹Ú°æÀÏ(µ¿¾ÆÀÇ´ë ¼øȯ±â³»°ú)

Åä·Ð 04¿ù 06ÀÏ Room1 12:40~12:50 Panel Discussion ()

ÈÞ½Ä 04¿ù 06ÀÏ 12:50~13:20 Break ()

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 13:30~13:50 KSoLA- Deciphering lipid enigmas: exploring TRL, triglycerides and remnant cholesterol as residual lipid risks and treatment targets ±èº´Áø(¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 13:50~14:10 KDA-  Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk ÀÌÁØ¿±(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 14:10~14:30 KSSO- CVOTs using non-GLP-1 based anti-obesity medications and bariatric surgery È«ÁØÈ­(À»ÁöÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 06ÀÏ Room1 14:30~15:00 Panel Discussion ()

ÈÞ½Ä 04¿ù 06ÀÏ 15:00~15:20 Break ()

±³À°½Ã°£ 04¿ù 06ÀÏ Room1,2,3 15:20~16:00 Two key biologic systems for cardiometabolic syndrome based on CAP1 : Resistin & PCSK9 ±èÈ¿¼ö(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú)

ÈÞ½Ä 04¿ù 06ÀÏ 16:00~16:10 Break ()

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 16:10~16:30 Dyslipidemia in Elderly-general concept ±è±¤ÁØ(¿¬¼¼ÀÇ´ë ³ë³â³»°ú)

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 16:30~16:50 Dyslipidemia in CKD À¯ÅÂÇö(¿¬¼¼ÀÇ´ë ½ÅÀå³»°ú)

±³À°½Ã°£ 04¿ù 06ÀÏ Room1 16:50~17:10 Dyslipidemia in adolescents and young adults ÀÌÀº¿µ(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 06ÀÏ Room1 17:10~17:40 Panel Discussion ()

±âŸ 04¿ù 06ÀÏ Room1,2,3 17:40~18:00 Closing Ceremony ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ Ãá°èÇмú´ëȸ (SoLA 2024) 2ÀÏÂ÷ : 2024-04-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2024³â Á¦1Â÷ ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° : 2024-04-07
´ÙÀ½±Û Á¦66Â÷ ´ëÇÑÀÌ°úÇÐȸ Çмú´ëȸ : 2024-04-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20649 ´ëÀü °ø°ø±â°ü ÀçÁ÷ÀÇ»ç Ãá°è Çмú´ëȸ (1ÀÏÂ÷) : 2024-05-23 0 0 16:03:32
20648 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦1Â÷¿¬¼ö±³À°(ºóÇ÷ ¹× ÃâÇ÷ Áúȯ, ÀÏÂ÷ ÀÇ·á±â°ü¿¡¼­ÀÇ °ü¸®) : 2024-05-23 0 0 16:02:06
20647 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ - Á¦2Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-23 0 0 16:00:41
20646 Á¦ÁÖ ´ëÇÑÇǺΰúÇÐȸ Á¦ÁÖÁöºÎȸ 2024³â Á¦1Â÷ Áý´ãȸ : 2024-05-22 0 0 15:59:09
20645 ´ë±¸ ´ëÇѾȰúÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö±³À°-¹é³»Àå ¹× Àü¾ÈºÎ ÃֽŠÁö°ß : 2024-05-21 0 0 15:57:33
20644 ¼­¿ï ¾çõ±¸ÀÇ»çȸ Ãá°è¿¬¼ö±³À°(Á¦2Çü ´ç´¢º´°ú ¸¸¼º ½ÅÀ庴, ÀÎÁöÀå¾Ö, ¸ÞŸ¹ö½º¿Í ÀÇ·á Çõ¸í) : 2024-05-21 0 0 15:55:38
20643 ÃæºÏ 2024 Á¦Ãµ½ÃÀÇ»çȸ Ãá°è ¿¬¼ö°­Á : 2024-05-21 0 0 15:53:46
20642 ºÎ»ê Á¦28Â÷ ¾Æ½Ã¾Æ-¿À¼¼¾Æ´Ï¾Æ »êºÎÀΰú¿¬¸Í Çмú´ëȸ (AOFOG 2024) (4ÀÏÂ÷) : 2024-05-20 0 0 15:52:12
20641 ¼­¿ï ´ëÇÑÀÓ»ó³ëÀÎÀÇÇÐȸ 2024 Ãá°è ³ëÀÎÀÇÇÐ ¿¬¼ö°­Á : 2024-05-19 0 0 15:48:53
20640 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇаúÀÇ»çȸ Stanley Lam ¿öÅ©¼¥ : 2024-05-19 0 0 15:47:30
20639 ¼­¿ï Á¦40ȸ ´ëÇѳëÀÎÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 0 15:46:20
20638 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2024³âµµ ¿¬¼ö°­Á : 2024-05-18 0 0 15:43:13
20637 ÀÎõ 2024³âµµ Á¦47Â÷ ´ëÇѺ¹ºÎ¿µ»óÀÇÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-05-18 0 0 15:39:29
20636 Àü³² 2024 Á¦2Â÷ ´ëÇѾȰúÀÇ»çȸ ½ÉÆ÷Áö¿ò : 2024-05-18 0 0 15:37:24
20635 ¼­¿ï ´ëÇÑÇǺκ´¸®ÇÐȸ Á¦22ȸ ÇǺκ´¸® ½ÉÆ÷Áö¿ò : 2024-05-18 0 0 15:36:02
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷